
Who We Are
BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.
Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.
Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of BioMarin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.
About Corporate Groups
It takes a village, and at BioMarin, our general and admin teams are the village behind our success. From the IT experts who manage our technology to the human resources professionals who hire the people who make it all possible, these teams support our organization and span all areas of operations
Associate Director, Commercial FP&A — Germany and Italy
London (Hybrid 2 days per week onsite)
Closing date: Friday 24th July 2026
About the Opportunity:
BioMarin’s Finance organization plays a critical role in enabling our business strategy, supporting disciplined investment decisions, and helping the company deliver on its commitment to patients. The team partners across functions and geographies to provide financial insight, planning rigor, operational accountability, and strategic decision support.
The Associate Director, Commercial FP&A, Germany and Italy is a key role responsible for revenue planning, forecasting, performance management, and decision support for the Germany and Italy businesses. This individual will serve as the primary Finance partner to the country leaders and will help translate commercial strategy, market dynamics, and business performance into clear financial insights and actionable recommendations.
The role will support the Annual Operating Plan (AOP), quarterly forecasts, Monthly Business Reviews (MBRs), Quarterly Business Reviews (QBRs), and ad hoc decision support for the respective countries. This individual will partner closely with their Commercial FP&A counterpart responsible for planning and managing OPEX for the broader region, ensuring strong alignment between revenue performance, investment priorities, and regional financial objectives.
This individual will also support the EUCAN FP&A lead on consolidating and crafting executive ready narratives, analyzing regional performance and decision support.
Leadership Responsibility:
Experience Required:
Required Skills:
Success Factors:
The successful candidate will be a commercially minded finance professional who combines financial rigor, strong analytical capability, and trusted business partnership. This individual will be a proactive individual contributor who can support country leaders, collaborate effectively with FP&A peers, and translate business complexity into clear financial insights and actionable decisions.
Note: This description is not intended to be all-inclusive or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.
Recruitment Fraud Alert Notice
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral.
In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit.
We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.